The 10 drugs costing Medicare the most:
1. Harvoni ($4.4 billion)
2. Revlimid ($2.6 billion)
3. Lantus Solostar ($2.5 billion)
4. Januvia ($2.4 billion)
5. Crestor ($2.3 billion)
6. Advair Diskus ($2.3 billion)
7. Lyrica ($2.1 billion)
8. Xarelto ($1.9 billion)
9. Eliquis ($1.9 billon)
10. Spiriva ($1.8 billion)
More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck’s Keytruda fails late-stage trial as standalone treatment for breast cancer
Register to Attend Webinar
Presenters:
Sherif ElMasry, Forus|Gary I. Kleiner, M.D., Ph.D., University of Miami Health System|Angela J Lamb, M.D., Mount Sinai
Next Up in Pharmacy
-
The FDA has approved AbbVie’s Juvmo (tavapadon) tablets for adults with Parkinson’s disease, making it the first and only selective…
-
Hospitals and health systems nationwide are seeking pharmacy leaders as the role expands amid drug pricing pressure, supply chain constraints…
-
The Pharmaceutical Research and Manufacturers of America filed a lawsuit Oct. 7 challenging CMS’ mandatory Global Benchmark for Efficient Drug…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
